J. B. Chemicals & Pharmaceuticals Management
Management Kriterienprüfungen 2/4
Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.
Wichtige Informationen
Nikhil Chopra
Geschäftsführender
₹65.4m
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | 56.4% |
| Amtszeit als Geschäftsführer | 3.5yrs |
| Eigentum des Geschäftsführers | n/a |
| Durchschnittliche Amtszeit des Managements | 1.4yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 3.8yrs |
Jüngste Management Updates
Recent updates
J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Apr 19
J. B. Chemicals & Pharmaceuticals Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 09J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Not Flying Under The Radar
Dec 22We Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Can Stay On Top Of Its Debt
Nov 29J. B. Chemicals & Pharmaceuticals' (NSE:JBCHEPHARM) Dividend Will Be Increased To ₹9.25
Aug 03J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Due To Pay A Dividend Of ₹8.50
Feb 11Is J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Using Too Much Debt?
Dec 03A Look At The Intrinsic Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Sep 21J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Seems To Use Debt Quite Sensibly
Aug 03Estimating The Fair Value Of J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
Jun 15Does J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Have A Healthy Balance Sheet?
Mar 29J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Has Re-Affirmed Its Dividend Of ₹8.50
Feb 16With EPS Growth And More, J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Is Interesting
Jan 27J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Could Easily Take On More Debt
Nov 30Here's Why I Think J. B. Chemicals & Pharmaceuticals (NSE:JBCHEPHARM) Might Deserve Your Attention Today
Sep 24Are J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Investors Paying Above The Intrinsic Value?
Aug 03Do J. B. Chemicals & Pharmaceuticals's (NSE:JBCHEPHARM) Earnings Warrant Your Attention?
Jun 14How Does J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM) Fare As A Dividend Stock?
May 04Do J. B. Chemicals & Pharmaceuticals's (NSE:JBCHEPHARM) Earnings Warrant Your Attention?
Mar 13Analyse der Geschäftsführervergütung
| Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | ₹6b |
| Dec 31 2023 | n/a | n/a | ₹5b |
| Sep 30 2023 | n/a | n/a | ₹5b |
| Jun 30 2023 | n/a | n/a | ₹4b |
| Mar 31 2023 | ₹65m | ₹37m | ₹4b |
| Dec 31 2022 | n/a | n/a | ₹4b |
| Sep 30 2022 | n/a | n/a | ₹4b |
| Jun 30 2022 | n/a | n/a | ₹4b |
| Mar 31 2022 | ₹59m | ₹18m | ₹4b |
| Dec 31 2021 | n/a | n/a | ₹4b |
| Sep 30 2021 | n/a | n/a | ₹5b |
| Jun 30 2021 | n/a | n/a | ₹4b |
| Mar 31 2021 | ₹32m | ₹7m | ₹4b |
Vergütung im Vergleich zum Markt: NikhilDie Gesamtvergütung ($USD787.86K) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt Indian ($USD509.33K).
Entschädigung vs. Einkommen: NikhilDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.
Geschäftsführer
Nikhil Chopra
3.5yrs
Amtszeit
₹65,448,000
Vergütung
Mr. Nikhil Ashokkumar Chopra serves as Chief Executive Officer and Whole-Time Director at J. B. Chemicals & Pharmaceuticals Limited since December 23, 2020 and has been its Director since May 10, 2020. He...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO & Whole-Time Director | 3.5yrs | ₹65.45m | keine Daten | |
| President of Operations | no data | ₹23.54m | keine Daten | |
| Vice President of HR & Administration | 8.4yrs | ₹11.55m | 0.00032% ₹ 866.0k | |
| Vice President of Legal | 1.3yrs | ₹1.63m | keine Daten | |
| President of Global Business | no data | ₹38.85m | 0.0039% ₹ 10.5m | |
| Executive Vice President of Operations of Daman | less than a year | ₹15.54m | 0.0055% ₹ 14.8m | |
| Executive Vice President of Supply Chain Operations | 1.4yrs | ₹17.60m | keine Daten | |
| Executive Vice President | less than a year | ₹14.33m | keine Daten | |
| President of India Business | no data | ₹23.86m | keine Daten | |
| President of R&D | no data | ₹12.34m | keine Daten | |
| Executive Vice President of Operations for Ankleshwar & Panoli | 1.4yrs | ₹15.86m | keine Daten | |
| Assistant Vice President | no data | ₹11.09m | 0% ₹ 0 |
1.4yrs
Durchschnittliche Betriebszugehörigkeit
47yo
Durchschnittliches Alter
Erfahrenes Management: JBCHEPHARMDas Führungsteam des Unternehmens gilt nicht als erfahren (1.3 Jahre durchschnittliche Betriebszugehörigkeit), was auf ein neues Team schließen lässt.
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO & Whole-Time Director | 3.7yrs | ₹65.45m | keine Daten | |
| Chairman of Biotech Laboratories (Pty ) Ltd | no data | keine Daten | keine Daten | |
| Non-Executive & Independent Director | 3.8yrs | ₹7.50m | keine Daten | |
| Non-Executive Director | 3.8yrs | keine Daten | keine Daten | |
| Non-Executive & Non-Independent Director | less than a year | keine Daten | keine Daten | |
| Non-Executive Director | 3.3yrs | keine Daten | keine Daten | |
| Non-Executive & Independent Director | 3.8yrs | ₹7.50m | keine Daten |
3.8yrs
Durchschnittliche Betriebszugehörigkeit
64.5yo
Durchschnittliches Alter
Erfahrener Vorstand: JBCHEPHARMDie Vorstandsmitglieder gelten als erfahren (3.7 Jahre durchschnittliche Amtszeit).